143 related articles for article (PubMed ID: 30833438)
1. Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.
Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2019 Mar; 29(3):497-504. PubMed ID: 30833438
[TBL] [Abstract][Full Text] [Related]
2. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
[TBL] [Abstract][Full Text] [Related]
3. The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study.
Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2019 Jan; 29(1):68-76. PubMed ID: 30640686
[TBL] [Abstract][Full Text] [Related]
4. The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():239-246. PubMed ID: 34247041
[TBL] [Abstract][Full Text] [Related]
5. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract][Full Text] [Related]
6. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
Eltabbakh GH; Piver MS; Hempling RE; Shin KH
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
[TBL] [Abstract][Full Text] [Related]
7. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
[TBL] [Abstract][Full Text] [Related]
10. Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA).
Bertelsen K; Ortoft G; Hansen ES
Int J Gynecol Cancer; 2011 Oct; 21(7):1191-9. PubMed ID: 21885985
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors.
Blecharz P; Brandys P; Urbański K; Reinfuss M; Patla A
Eur J Gynaecol Oncol; 2011; 32(4):403-7. PubMed ID: 21941962
[TBL] [Abstract][Full Text] [Related]
14. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
16. Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: the Danish Endometrial Cancer Study.
Ørtoft G; Hansen ES; Bertelsen K
Int J Gynecol Cancer; 2013 Oct; 23(8):1429-37. PubMed ID: 24257557
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
Xu MJ; Chu C; Rubin S; Lin LL
Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
[TBL] [Abstract][Full Text] [Related]
19. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
Sorbe B; Söderström K
Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
[TBL] [Abstract][Full Text] [Related]
20. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
